Xiaofei Zhu

changhai hospital affiliated to naval medical university

H指数:18

被引数:1,083

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Multifunctional Nanovaccine-Radiotherapy Synergy Drives Anti-Tumor Immunity via Multi-Cascade Cell Death for Pancreatic Cancer Therapy

多功能纳米疫苗-放疗协同作用通过多级联细胞死亡驱动抗肿瘤免疫以治疗胰腺癌

Advanced Science

IF14.1

2026-09-110

OAAI

Stage III Lymph Node-Positive Non-Small-Cell Lung Cancer Patients With or Without Lymph Node Irradiation by Stereotactic Body Radiation Therapy: Propensity Score-Matched Analysis

III期淋巴结阳性非小细胞肺癌患者采用立体定向体部放射治疗进行或不进行淋巴结照射：倾向性评分匹配分析

Clinical Respiratory Journal

IF2.3

2026-05-080

OAAI

ADJUPANC protocol: a phase III study of adjuvant chemotherapy versus chemoradiotherapy for pancreatic cancer

ADJUPANC协议：一项关于胰腺癌辅助化疗与化学放疗比较的III期研究

Future Oncology

IF2.6

2025-06-290

PRE

Central-boost Ablative Radiation Therapy for Solid Tumors: Study Protocol of a Single-arm, Phase II Trial (CBART)

中央提升式烧蚀放射疗法治疗实体瘤：一项单臂、II期试验（CBART）的研究方案

Technology in Cancer Research & Treatment

IF2.8

2025-06-120

Hydroxyl-modified fullerene C70(OH)8 induces pyroptosis for cancer therapy

羟基修饰的富勒烯C70(OH)8诱导焦亡以用于癌症治疗

INORGANIC CHEMISTRY FRONTIERS

IF6.4

2025-01-010

PRE

A novel NIR fluorescent probe to image HNO during ferroptosis

一种新型的近红外荧光探针在铁死亡过程中对HNO成像

ANALYTICA CHIMICA ACTA

IF6

2024-11-011

PRE

Stereotactic body radiation therapy for the primary tumor and oligometastases versus the primary tumor alone in patients with metastatic pancreatic cancer

转移性胰腺癌患者的原发性肿瘤和寡转移的立体定向放射治疗与单独的原发性肿瘤治疗

RADIATION ONCOLOGY

IF3.2

2024-08-192

OAAI

Research reviews and prospects of gut microbiota in liver cirrhosis: a bibliometric analysis (2001-2023)

FRONTIERS IN MICROBIOLOGY

IF4.5

2024-03-148

OAAI

Genome-Wide Association Analysis of Seed Vigor-Related Traits in Wheat

AGRONOMY-BASEL

IF3.4

2024-02-200

Efficacy and toxicity of stereotactic body radiotherapy for un-resectable stage III non-small cell lung cancer patients unfit for concurrent chemoradiation therapy: a retrospective study (vol 18, 140, 2023)

RADIATION ONCOLOGY

IF3.2

2023-10-110

OAAI

Efficacy and toxicity of stereotactic body radiotherapy for un-resectable stage III non-small cell lung cancer patients unfit for concurrent chemoradiation therapy: a retrospective study

RADIATION ONCOLOGY

IF3.2

2023-08-243

OAAI

Alterations in the intestinal microbiome and metabolic profile of patients with cirrhosis supplemented with lactulose, Clostridium butyricum, and Bifidobacterium longum infantis: a randomized placebo-controlled trial

FRONTIERS IN MICROBIOLOGY

IF4.5

2023-04-265

OAAI

The mechanism of microglia-mediated immune inflammation in ischemic stroke and the role of natural botanical components in regulating microglia: A review

FRONTIERS IN IMMUNOLOGY

IF5.9

2023-02-0260

OAAI

Dose evaluations of organs at risk and predictions of gastrointestinal toxicity after re-irradiation with stereotactic body radiation therapy for pancreatic cancer by deformable image registration

FRONTIERS IN ONCOLOGY

IF3.3

2023-01-301

OAAI

Effect of stereotactic body radiotherapy dose escalation plus pembrolizumab and trametinib versus stereotactic body radiotherapy dose escalation plus gemcitabine for locally recurrent pancreatic cancer after surgical resection on survival outcomes: A secondary analysis of an open-label, randomised, controlled, phase 2 trial

ECLINICALMEDICINE

IF10

2023-01-017

OAAI

Protocol of the integrated boost to the dominant intraprostatic nodule in stereotactic body radiation therapy for localized prostate cancer

FUTURE ONCOLOGY

IF2.6

2022-12-121

PRE

New Staging Model for Radiation-based Hepatocellular Carcinoma Treatment: A National Multicenter Study

clinical and translational gastroenterology

IF4.2

2022-05-242

OAAI

Re-Irradiation With Stereotactic Body Radiotherapy for In-Field Recurrence of Pancreatic Cancer After Prior Stereotactic Body Radiotherapy: Analysis of 24 Consecutive Cases

FRONTIERS IN ONCOLOGY

IF3.3

2021-11-023

OAAI

Lactitol Supplementation Modulates Intestinal Microbiome in Liver Cirrhotic Patients

FRONTIERS IN MEDICINE

IF3

2021-10-1410

OAAI

Stereotactic body radiation therapy with sequential S-1 for patients with locally advanced pancreatic cancer and poor performance status: An open-label, single-arm, phase 2 trial

RADIOTHERAPY AND ONCOLOGY

IF5.3

2021-09-017

PRE

Xiaofei Zhu

个人简介

教育背景

工作经历

荣誉奖项

研究方向